title: Growth factor receptors as regulators of hematopoiesis.
abstract: Nearly 15 years have elapsed since the US Food and Drug Administration last approved a major new hematopoietic cytokine. Promiscuous binding to multiple receptors, or to receptors expressed by multiple tissues, reduces growth factor specificity and promotes side effects. Here we show that hematopoiesis can be differentially regulated using receptors rather than ligands. Conditional derivatives of both fibroblast growth factor receptor-1 (F36VFGFR1) and the thrombopoietin receptor (F36VMpl) induced a sustained expansion of mouse marrow cells ex vivo, and erythroid cells in vivo. Only F36VFGFR1 could support the ex vivo expansion of short-term repopulating hematopoietic stem cells (HSCs), the ex vivo survival of long-term repopulating HSCs, and the prolonged in vivo expansion of granulocytes, monocytes, and platelets. Only F36VMpl induced a response sufficiently rapid to accelerate recovery from radiation-induced anemia. These results establish receptors as a new class of hematopoietic regulators possessing activities unobtainable with growth factors.
authors.affiliation: Division of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Weinreich
authors.forename: Ingrid
authors.initials: I
authors.lastname: Lintmaer
authors.forename: Linlin
authors.initials: L
authors.lastname: Wang
authors.forename: H Denny
authors.initials: HD
authors.lastname: Liggitt
authors.forename: Michael A
authors.initials: MA
authors.lastname: Harkey
authors.forename: C Anthony
authors.initials: CA
authors.lastname: Blau
mesh_terms: D019943:Amino Acid Substitution; D000740:Anemia / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D000818:Animals; D001854:Bone Marrow Cells; D002470:Cell Survival / Q000235:genetics; D015672:Erythroid Precursor Cells / Q000166:cytology / Q000378:metabolism; D005260:Female; D015316:Genetic Therapy; D006410:Hematopoiesis / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000378:metabolism*; D007962:Leukocytes / Q000166:cytology / Q000378:metabolism; D051379:Mice; D008817:Mice, Mutant Strains; D020125:Mutation, Missense; D011833:Radiation Injuries, Experimental / Q000235:genetics / Q000401:mortality / Q000628:therapy; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics / Q000378:metabolism*; D053628:Receptors, Thrombopoietin / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014161:Transduction, Genetic; D018183:Transplantation Chimera / Q000235:genetics / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D053628:Receptors, Thrombopoietin; C496349:Fgfr1 protein, mouse; D051496:Receptor, Fibroblast Growth Factor, Type 1